Effect of semaglutide treatment on chronic kidney disease in patients with type 2 diabetes: results from the FLOW study

Czech version

Authors: Pavlína Piťhová
Published in: AtheroRev 2024; 9(2): 103-104
Category:

Sources

Perkovic V, Tuttle KR, Rossing P et al. [FLOW Trial Committees and Investigators]. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N Engl J Med 2024; 391(2): 109–121. Dostupné z DOI: <https://doi 10.1056/NEJMoa2403347>.

Labels

Angiology Diabetology Internal medicine Cardiology General practitioner for adults

Editorial

Diagnosis and treatment of hyperuricemia in cardiovascular prevention based on the pathophysiological mechanism of its occurrence: expert consensus of Czech and Slovak experts 2024

Inertia – a possible reason for not reaching LDL-cholesterol targets: results of a multicenter observational study

The current role of lipoprotein apheresis in the context of new recommendations for hypolipidemic pharmacotherapy

Cell-free DNAs in plasma and cardiovascular medicine – their potential

Bempedoic acid – a new player in the field of hypolipidemic therapy

Jan Piťha and Vladimír Blaha jubilating

Research on remarkable articles from international literature

27th Congress of Atherosclerosis

Article was published in

Athero Review

2024 Issue 2